Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.73B |
| 2 |
Tesla
TSLA
|
+$1.4B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 4 |
Altria Group
MO
|
+$1.19B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$777M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.42B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.3B |
| 3 |
Uber
UBER
|
+$1.25B |
| 4 |
RTX Corp
RTX
|
+$1.08B |
| 5 |
Danaher
DHR
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.3% |
| 2 | Technology | 21.37% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
| $1.88B | 0.15% |
22,520,770
+4,737,966
| +27% | +$382M |
|
127
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.88B | 0.15% |
45,043,160
-663,383
| -1% | -$27.1M |
|
128
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $1.87B | 0.15% |
17,975,068
-2,087,850
| -10% | -$211M |
|
129
Lam Research
LRCX
$342B
| $1.86B | 0.15% |
19,116,840
+798,200
| +4% | +$70.2M |
|
130
Stryker
SYK
$108B
| $1.86B | 0.15% |
5,187,585
-262,404
| -5% | -$88.3M |
|
131
CrowdStrike
CRWD
$241B
| $1.85B | 0.15% |
23,143,192
+1,896,372
| +9% | +$145M |
|
132
Micron Technology
MU
$1.04T
| $1.85B | 0.15% |
15,666,896
+1,699,325
| +12% | +$154M |
|
133
Trade Desk
TTD
$7.03B
| $1.81B | 0.15% |
20,760,269
-2,218,184
| -10% | -$168M |
|
134
Vanguard Morningstar Mid-Cap ETF
VO
$105B
| $1.8B | 0.14% |
28,804,864
+661,324
| +2% | +$39.1M |
|
135
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
| $1.73B | 0.14% |
11,679,679
-354,686
| -3% | -$50.9M |
|
136
GE Aerospace
GE
$329B
| $1.72B | 0.14% |
12,299,846
+159,321
| +1% | +$18.8M |
|
137
CDW
CDW
$19.2B
| $1.71B | 0.14% |
6,699,262
-159,535
| -2% | -$37.9M |
|
138
Progressive
PGR
$126B
| $1.7B | 0.14% |
8,234,239
+652,949
| +9% | +$121M |
|
139
Boeing
BA
$166B
| $1.7B | 0.14% |
8,797,721
-218,388
| -2% | -$44.9M |
|
|
SCHW
140
Charles Schwab
SCHW
$185B
| $1.68B | 0.14% |
23,289,117
-1,636,402
| -7% | -$108M |
|
141
Constellation Brands
STZ
$20.9B
| $1.68B | 0.14% |
6,193,711
+1,925,315
| +45% | +$487M |
|
142
Colgate-Palmolive
CL
$69.2B
| $1.65B | 0.13% |
18,316,984
-1,088,508
| -6% | -$92.2M |
|
143
Strategy Inc
MSTR
$54.4B
| $1.64B | 0.13% |
9,643,590
+3,619,180
| +60% | +$330M |
|
144
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
| $1.64B | 0.13% |
7,187,492
+169,696
| +2% | +$36.5M |
|
145
ASML
ASML
$605B
| $1.63B | 0.13% |
1,678,448
+312,632
| +23% | +$277M |
|
146
Citigroup
C
$228B
| $1.63B | 0.13% |
25,707,757
-2,734,206
| -10% | -$152M |
|
147
American Tower
AMT
$82.9B
| $1.62B | 0.13% |
8,187,899
+831,645
| +11% | +$166M |
|
148
Emerson Electric
EMR
$84.9B
| $1.62B | 0.13% |
14,250,185
+745,681
| +6% | +$76.6M |
|
149
iShares MSCI Japan ETF
EWJ
$23.5B
| $1.61B | 0.13% |
22,512,324
+3,790,594
| +20% | +$257M |
|
150
Bristol-Myers Squibb
BMY
$130B
| $1.59B | 0.13% |
29,269,610
-111,861
| -0.4% | -$5.7M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,146 positions worth $1.25T, up 9.8% from $1.13T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley's Q1 2024 filing shows 340 new, 3,230 increased, 3,352 reduced and 318 closed positions. Its largest new stake was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M. The largest sale was Philip Morris, an estimated $1.42B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to UnitedHealth in Q1 2024, an estimated $1.73B increase.
- Morgan Stanley's biggest Q1 2024 reduction was Philip Morris, cutting an estimated $1.42B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $362M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 340 new positions and closed 318 in Q1 2024.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.